Prophylactic effect of Malarone against malaria: all good news? (Q39309836)

10 September 2017

Prophylactic effect of Malarone against malaria: all good news? (English)

1 reference

10 September 2017

0 references

F Nosten

1

1 reference

PubMed ID

11130375

10 September 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

10 September 2017

1 reference

10 September 2017

356

1 reference

10 September 2017

9245

1 reference

10 September 2017

1864-1865

1 reference

Atovaquone and proguanil for Plasmodium falciparum malaria.

10 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903250-5

7 January 2021

Doctors revise declaration of Helsinki

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903250-5

7 January 2021

Examination of some factors responsible for a food-induced increase in absorption of atovaquone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903250-5

7 January 2021

The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903250-5

7 January 2021

Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903250-5

7 January 2021

Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903250-5

7 January 2021

Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903250-5

7 January 2021

A mechanism for the synergistic antimalarial action of atovaquone and proguanil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903250-5

7 January 2021

Sustainability, affordability, and equity of corporate drug donations: the case of Malarone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903250-5

7 January 2021

Malarone-donation programme in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903250-5

7 January 2021

10.1016/S0140-6736(00)03250-5

Identifiers

DOI

1 reference

10 September 2017

1 reference

PubMed ID

11130375